The Antiproteinuric Effect of Angiotensin-Converting-Enzyme Inhibitors in Human Renal Disease

作者: Dick de Zeeuw , Jan E. Heeg , Paul E. de Jong

DOI: 10.1007/978-1-4471-1892-3_4

关键词: Angiotensin-converting enzymeReabsorptionEndocrinologyBlood proteinsDiabetic nephropathyFiltration fractionChemistryProteinuriaAlbuminInternal medicineGlomerular Filtration Barrier

摘要: Many renal diseases are accompanied by an excess loss of plasma proteins in the urinary space. As such proteinuria has been successfully used as a tool both to detect presence disease and evaluate success therapeutic interventions on activity. The quantity quality protein leakage may some cases distinguish between different underlying causes disease. In case minimalchange disease, is usually excreted considerable quantities, largely confined albumin, whereas specific tubular rather small consisting mainly low-molecular-weight proteins. However, general, does not differentiate multiple insults, suggesting more or less common cause pathway loss. Indeed, be discriminating properties glomerular filtration barrier for macromolecules. health, this prevents space at least two selective mechanisms. Firstly, pores limited size, hindering passage macromolecules larger than ≈55 Angstrom (size selectivity). Secondly, negative charges embedded prevent main negatively-charged protein, albumin (charge Furthermore, proximal reabsorption those that escape these restrictive properties.

参考文章(67)
J. E. Hall, T. G. Coleman, A. C. Guyton, P. R. Kastner, J. P. Granger, Control of glomerular filtration rate by circulating angiotensin II. American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 241, ,(1981) , 10.1152/AJPREGU.1981.241.3.R190
Yoshio Taguma, Yasunori Kitamoto, Gen Futaki, Hitoshi Ueda, Hiromichi Monma, Makoto Ishizaki, Hisashi Takahashi, Hiroshi Sekino, Yasuhiko Sasaki, Effect of Captopril on Heavy Proteinuria in Azotemic Diabetics New England Journal of Medicine. ,vol. 313, pp. 1617- 1620 ,(1985) , 10.1056/NEJM198512263132601
H. Herlitz, C. Edenö, H. Mulec, G. Westberg, M. Aurell, Captopril treatment of hypertension and renal failure in systemic lupus erythematosus. Nephron. ,vol. 38, pp. 253- 256 ,(1984) , 10.1159/000183318
S Bjorck, H Mulec, S A Johnsen, G Nyberg, M Aurell, Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ. ,vol. 300, pp. 904- 907 ,(1990) , 10.1136/BMJ.300.6729.904
E Hommel, H H Parving, E Mathiesen, B Edsberg, M Damkjaer Nielsen, J Giese, Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. BMJ. ,vol. 293, pp. 467- 470 ,(1986) , 10.1136/BMJ.293.6545.467
Yoshiyuki Yoshida, Agnes Fogo, Iekuni Ichikawa, Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis Kidney International. ,vol. 35, pp. 654- 660 ,(1989) , 10.1038/KI.1989.35
Peter C. Brazy, William W. Stead, James F. Fitzwilliam, Progression of renal insufficiency: role of blood pressure. Kidney International. ,vol. 35, pp. 670- 674 ,(1989) , 10.1038/KI.1989.37
JohanB. Rosman, PietM. Ter Wee, Sijtze Meijer Truus, Ph.M. Piers-Becht, WimJ. Sluiter, AbJ.M. Donker, Prospective randomised trial of early dietary protein restriction in chronic renal failure The Lancet. ,vol. 2, pp. 1291- 1296 ,(1984) , 10.1016/S0140-6736(84)90818-3